Michelle Greer, RN, IgCN
Executive Vice President, Sales
Marianna Herrera, BSN, RN, IgCN is a Clinical Nurse Educator at Nufactor Specialty Pharmacy. Marianna has over 25 years of infusion therapy experience, specializing in immunoglobulin therapy and a wide range of biologic, monoclonal antibody, and specialty medications. She earned her Bachelor of Nursing degree from the University of Texas at El Paso. Marianna is a member of Immunoglobulin National Society (IgNS) and Texas Association of Nurse Anesthetists. An Immunoglobulin Certified Nurse (IgCN), Marianna empowers clinicians through training nurses and home health agencies on the administration of Nufactor’s therapies and providing continuing education on immune globulin and infliximab therapies. Marianna also supports and educates patients and caregivers on their disease states and possible adverse events, ensuring patients feel supported throughout their treatment journey.
Michelle's Recent Posts
Positivity
Since we are all individuals, it’s up to you to decide how to actively stay positive. I recently read a devotional that listed six attributes of staying positive, and I would like to pass them on to you.
Who To Call and When: A Guide to Communication With MD and Pharmacist Part 2
By Michelle Greer, RN, IgCN. In our last blog, we talked about some of the more common side effects and when to communicate with the MD and the pharmacist. For Part 2, let’s talk about some additional side effects as well as signs and symptoms of more severe adverse events associated with immune globulin therapy.
Who To Call and When: A Guide to Communication With The MD and Pharmacist Part 1
By Michelle Greer, RN, IgCN. In the support of our patients in the homecare setting, it is imperative as nurses that we know when to notify the physician and pharmacist for patients receiving immune globulin therapy. IG therapy does have side effects, and it is important to recognize them and know what to do. Every patient will react differently to IG therapy. Some patients may experience no side effects at all, while others may have mild to moderate reactions. This goes for both IV and SC therapy. The management of IVIG and SCIG infusion side effects is crucial to the overall tolerability of IG therapy.
Pre-visit/Visit Preparation: Vital Tasks for a Successful Infusion
By Michelle Greer, RN, IgCN and Cindi Berry, RN, BSN. When working in homecare, preparing to see your patient for intravenous immune globulin (IVIG) therapy can be challenging and requires a good deal of preparation. Many times, it is up to you, the registered nurse, to put together some of the information prior to seeing your patient. This information includes doctor visit notes, current orders prescribed by the doctor, specialty pharmacy orders and supplies, and knowing the type of therapy that will be administered in the home. In addition, since there are many different brands and doses of IG, you should be familiar with both of these prior to seeing your patient in the home.
Weaning IVIG Therapy for CIDP
Previously we began discussing how to wean patients with CIDP off IVIg therapy. In this week’s blog, we address common fears and questions. As well as when and how to implement a tapering plan.
International Pemphigus Pemphigoid Foundation Hosts Annual Meeting
The recent conference hosted by the International Pemphigus Pemphigoid Foundation (IPPF), offered helpful insights, panel discussions and advocacy advice for patients and physicians.
